DNA damage, apoptosis and langerhans cells - Activators of UV-induced immune tolerance

被引:80
作者
Timares, Laura [1 ,2 ,3 ]
Katiyar, Santosh K. [1 ]
Elmets, Craig A. [1 ]
机构
[1] Univ Alabama Birmingham, Dept Dermatol, UAB Skin Dis Res Ctr, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Div Human Gene Therapy, Dept Cell Biol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Div Human Gene Therapy, Dept Pathol, Birmingham, AL 35294 USA
关键词
D O I
10.1111/j.1751-1097.2007.00284.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Solar UVR is highly mutagenic but is only partially absorbed by the outer stratum corneum of the epidermis. UVR can penetrate into the deeper layers of the epidermis, depending on melanin content, where it induces DNA damage and apoptosis in epidermal cells, including those in the germinative basal layer. The cellular decision to initiate either cellular repair or undergo apoptosis has evolved to balance the acute need to maintain skin barrier function with the long-term risk of retaining precancerous cells. Langerhans cells (LCs) are positioned suprabasally, where they may sense UV damage directly, or indirectly through recognition of apoptotic vesicles and soluble mediators derived from surrounding keratinocytes. Apoptotic vesicles will contain UV-induced altered proteins that may be presented to the immune system as foreign. The observation that UVR induces immune tolerance to skin-associated antigens suggests that this photodamage response has evolved to preserve the skin barrier by protecting it from autoimmune attack. LC involvement in this process is not clear and controversial. We will highlight some basic concepts of photobiology and review recent advances pertaining to UV-induced DNA damage, apoptosis regulation, novel immunomodulatory mechanisms and the role of LCs in generating antigen-specific regulatory T cells.
引用
收藏
页码:422 / 436
页数:15
相关论文
共 169 条
[1]   Specificity in stress response: Epidermal keratinocytes exhibit specialized UV-responsive signal transduction pathways [J].
Adachi, M ;
Gazel, A ;
Pintucci, G ;
Shuck, A ;
Shifteh, S ;
Ginsburg, D ;
Rao, LS ;
Kaneko, T ;
Freedberg, IM ;
Tamaki, K ;
Blumenberg, M .
DNA AND CELL BIOLOGY, 2003, 22 (10) :665-677
[2]   Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases [J].
Adorini, L ;
Penna, G ;
Giarratana, N ;
Uskokovic, M .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) :227-233
[3]   Epidermal viral immunity induced by CD8α+ dendritic cells but not by Langerhans cells [J].
Allan, RS ;
Smith, CM ;
Belz, GT ;
van Lint, AL ;
Wakim, LM ;
Heath, WR ;
Carbone, FR .
SCIENCE, 2003, 301 (5641) :1925-1928
[4]   Rethinking the role of tumour necrosis factor-α in ultraviolet (UV) B-induced immunosuppression:: altered immune response in UV-irradiated TNFR1R2 gene-targeted mutant mice [J].
Amerio, P ;
Toto, P ;
Feliciani, C ;
Suzuki, H ;
Shivji, G ;
Wang, B ;
Sauder, DN .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (05) :952-957
[5]   THE OPTICS OF HUMAN-SKIN [J].
ANDERSON, RR ;
PARRISH, JA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1981, 77 (01) :13-19
[6]   Langerhans cells develop from a lymphoid-committed precursor [J].
Anjuère, F ;
del Hoyo, GM ;
Martín, P ;
Ardavín, C .
BLOOD, 2000, 96 (05) :1633-1637
[7]   Langerhans cells acquire a CD8+dendritic cell phenotype on maturation by CD40 ligation [J].
Anjuère, F ;
del Hoyo, GM ;
Martín, P ;
Ardavín, C .
JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (02) :206-209
[8]   Involvement of dectin-2 in ultraviolet radiation-induced tolerance [J].
Aragane, Y ;
Maeda, A ;
Schwarz, A ;
Tezuka, T ;
Ariizumi, K ;
Schwarz, T .
JOURNAL OF IMMUNOLOGY, 2003, 171 (07) :3801-3807
[9]   Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L [J].
Aragane, Y ;
Kulms, D ;
Metze, D ;
Wilkes, G ;
Pöppelmann, B ;
Luger, TA ;
Schwarz, T .
JOURNAL OF CELL BIOLOGY, 1998, 140 (01) :171-182
[10]   SKIN-CANCER [J].
ARMSTRONG, BK ;
KRICKER, A .
DERMATOLOGIC CLINICS, 1995, 13 (03) :583-594